BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol 2018;40:476-82. [PMID: 30111198 DOI: 10.1080/08923973.2018.1469145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Khatri V, Kalyanasundaram R. Therapeutic implications of inflammasome in inflammatory bowel disease. FASEB J 2021;35:e21439. [PMID: 33774860 DOI: 10.1096/fj.202002622R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Aziz SG, Pourheydar B, Chodari L, Hamidifar F. Effect of exercise and curcumin on cardiomyocyte molecular mediators associated with oxidative stress and autophagy in aged male rats. Microvasc Res 2022;:104380. [PMID: 35597271 DOI: 10.1016/j.mvr.2022.104380] [Reference Citation Analysis]
3 Dashdondov O, Wazir J, Sukhbaatar G, Mikrani R, Dorjsuren B, Aktar N, Zhou X. Herbal nutraceutical treatment of chronic prostatitis-chronic pelvic pain syndrome: a literature review. Int Urol Nephrol 2021;53:1515-28. [PMID: 33907984 DOI: 10.1007/s11255-021-02868-w] [Reference Citation Analysis]
4 Chen L, Shao J, Luo Y, Zhao L, Zhao K, Gao Y, Wang S, Liu Y. An integrated metabolism in vivo analysis and network pharmacology in UC rats reveal anti-ulcerative colitis effects from Sophora flavescens EtOAc extract. J Pharm Biomed Anal 2020;186:113306. [PMID: 32371325 DOI: 10.1016/j.jpba.2020.113306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
6 Gao W, Wang C, Yu L, Sheng T, Wu Z, Wang X, Zhang D, Lin Y, Gong Y. Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway. Biomed Res Int 2019;2019:6769789. [PMID: 31139644 DOI: 10.1155/2019/6769789] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
7 Zhong Y, Kang Z, Wang M, Long J, Wang H, Huang J, Wei S, Zhou W, Zhao H, Liu D. Curcumin ameliorated dextran sulfate sodium-induced colitis via regulating the homeostasis of DCs and Treg and improving the composition of the gut microbiota. Journal of Functional Foods 2021;86:104716. [DOI: 10.1016/j.jff.2021.104716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zheng T, Wang X, Chen Z, He A, Zheng Z, Liu G. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2020;35:722-9. [PMID: 31696975 DOI: 10.1111/jgh.14911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Liu S, Li Q, Liu F, Cao H, Liu J, Shan J, Dan W, Yuan J, Lin J. Uncovering the Mechanism of Curcuma in the Treatment of Ulcerative Colitis Based on Network Pharmacology, Molecular Docking Technology, and Experiment Verification. Evid Based Complement Alternat Med 2021;2021:6629761. [PMID: 34221084 DOI: 10.1155/2021/6629761] [Reference Citation Analysis]
10 Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019;25:4796-804. [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
11 Liu F, Yao Y, Lu Z, Zhang Q, Liu C, Zhu C, Lin C. 5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-κB/p65 signaling pathway. Phytomedicine 2021;82:153438. [PMID: 33422953 DOI: 10.1016/j.phymed.2020.153438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Parlakpinar H, Gunata M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacol Immunotoxicol 2021;43:651-65. [PMID: 34415233 DOI: 10.1080/08923973.2021.1966033] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shakour N, Cabezas R, Santos JG, Barreto GE, Jamialahmadi T, Hadizadeh F, Sahebkar A. Curcumin Can Bind and Interact with CRP: An in silico Study. Adv Exp Med Biol 2021;1308:91-100. [PMID: 33861438 DOI: 10.1007/978-3-030-64872-5_7] [Reference Citation Analysis]
14 Liu F, Wang X, Li D, Cui Y, Li X. Apple polyphenols extract alleviated dextran sulfate sodium-induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis. Phytother Res 2021;35:1468-85. [PMID: 33215776 DOI: 10.1002/ptr.6910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lu PD, Zhao YH. Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 2020;15:15. [PMID: 32063999 DOI: 10.1186/s13020-020-0296-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
16 Ailioaie LM, Ailioaie C, Litscher G. Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer. Pharmaceutics 2021;13:1562. [PMID: 34683855 DOI: 10.3390/pharmaceutics13101562] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Qi Q, Zhong R, Liu YN, Zhao C, Huang Y, Lu Y, Ma Z, Zheng HD, Wu LY. Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics. World J Gastroenterol 2022; 28(28): 3644-3665 [DOI: 10.3748/wjg.v28.i28.3644] [Reference Citation Analysis]
18 Mueller A, Brockmueller A, Kunnumakkara AB, Shakibaei M. Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis. Nutrients 2022;14:2030. [DOI: 10.3390/nu14102030] [Reference Citation Analysis]
19 Yang Z, Liu W, Zhou X, Zhu X, Suo F, Yao S. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22916. [PMID: 33120843 DOI: 10.1097/MD.0000000000022916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Shao BZ, Wang SL, Pan P, Yao J, Wu K, Li ZS, Bai Y, Linghu EQ. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation. Inflammation. 2019;42:1147-1159. [PMID: 30937839 DOI: 10.1007/s10753-019-01008-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
21 Xu H, Luo R, Dong L, Pu X, Chen Q, Ye N, Qi S, Han X, Nie W, Fu C, Hu Y, Zhang J, Gao F. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Nanomedicine 2022;39:102461. [PMID: 34562656 DOI: 10.1016/j.nano.2021.102461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
22 Rattis BAC, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19. Front Pharmacol 2021;12:675287. [PMID: 34025433 DOI: 10.3389/fphar.2021.675287] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Cao SY, Ye SJ, Wang WW, Wang B, Zhang T, Pu YQ. Progress in active compounds effective on ulcerative colitis from Chinese medicines. Chin J Nat Med 2019;17:81-102. [PMID: 30797423 DOI: 10.1016/S1875-5364(19)30012-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Des Devel Ther 2021;15:4503-25. [PMID: 34754179 DOI: 10.2147/DDDT.S327378] [Reference Citation Analysis]
25 Yedjou CG, Njiki S, Enow J, Ikome O, Latinwo L, Long R, Ngnepieba P, Alo RA, Tchounwou PB. Pharmacological Effects of Selected Medicinal Plants and Vitamins Against COVID-19. J Food Nutr (Frisco) 2021;7:202. [PMID: 34395868 DOI: 10.17303/jfn.2021.7.202] [Reference Citation Analysis]
26 Yin J, Wei L, Wang N, Li X, Miao M. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115041] [Reference Citation Analysis]
27 Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): New treatment option against COVID-19. Food Sci Nutr 2020;8:5215-27. [PMID: 33133525 DOI: 10.1002/fsn3.1858] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
28 Dong X, Tong Y. Curcumin Nanoparticles Inhibit Liver Cancer by Inhibiting Angiogenesis. sci adv mater 2021;13:1878-84. [DOI: 10.1166/sam.2021.4118] [Reference Citation Analysis]
29 Xu X, Li J, Long X, Tao S, Yu X, Ruan X, Zhao K, Tian L. C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome. Front Pharmacol 2021;12:707610. [PMID: 34322027 DOI: 10.3389/fphar.2021.707610] [Reference Citation Analysis]
30 Appleton L, Day AS. Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome. J Clin Med 2019;8:E1885. [PMID: 31698718 DOI: 10.3390/jcm8111885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]